Charette; Marc F.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Charette; Marc F..The latest application filed is for "conjoint administration of morphogens and ace inhibitors in treatment of chronic renal failure".

Company Profile

0.11.6

Charette; Marc F. - Needham MA
Charette; Marc F. - West Roxbury MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Synergistic effects of OP/BMP morphogens and GDNF/NGF neurotrophic factors Grant 7,507,709 - Charette , et al. March 24, 2	2009-03-24
Product and process for the production, isolation, and purification of recombinant polypeptide Grant 7,105,638 - Huston , et al. September 12, 2	2006-09-12
Morphogen treatments for limiting proliferation of epithelial cells Grant 7,060,680 - Cohen , et al. June 13, 2	2006-06-13
Conjoint administration of morphogens and ACE inhibitors in treatment of chronic renal failure App 20050272649 - Hruska, Keith A. ; et al.	2005-12-08
Synergistic effects of OP/BMP morphogens and GDNF/NGF neurotrophic factors Grant 6,936,582 - Charette , et al. August 30, 2	2005-08-30
Synergistic effects of OP/BMP morphogens and GDNF/NGF neurotrophic factors App 20050164938 - Charette, Marc F. ; et al.	2005-07-28
Methods and compositions for enhancing cognitive function using morphogenic proteins App 20040176292 - Charette, Marc F.	2004-09-09
Methods And Compositions For Enhancing Cognitive Function Using Morphogenic Proteins App 20030170213 - CHARETTE, MARC F.	2003-09-11
Morphogen treatments for limiting proliferation of epithelial cells App 20030125230 - Cohen, Charles M. ; et al.	2003-07-03
Methods for enhancing functional recovery following central nervous system ischemia or trauma App 20030022830 - Charette, Marc F. ; et al.	2003-01-30
Method for enhancing functional recovery following central nervous system ischemia or trauma Grant 6,407,060 - Charette , et al. June 18, 2	2002-06-18
Morphogen treatment of gastrointestinal ulcers Grant 5,972,884 - Cohen , et al. October 26, 1	1999-10-26
Production of platelet derived growth factor (PDGF) an muteins thereof Grant 5,759,815 - Charette , et al. June 2, 1	1998-06-02
Morphogen treatment of gastrointestinal ulcers Grant 5,739,107 - Cohen , et al. April 14, 1	1998-04-14
Method for promoting tissue repair and regeneration using PDGF and glucocorticoids Grant 5,376,636 - Rutherford , et al. * December 27, 1	1994-12-27
Method of treating gastrointestinal ulcers with platelet derived growth factor Grant 5,234,908 - Szabo , et al. August 10, 1	1993-08-10
Product and process for introduction of a hinge region into a fusion protein to facilitate cleavage Grant 5,013,653 - Huston , et al. May 7, 1	1991-05-07

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.